Article
Pulmonary Alveolar Microlithiasis: A Review of a Rare Disease Through Rarely Discussed Perspectives.
Seminars in respiratory and critical care medicine - 1 Aug 2026
Altınışık Göksel, Yiğit Nilüfer, Çetin Nazlı
Abstract excerpt
Abstract: Pulmonary alveolar microlithiasis (PAM) has been well characterized in terms of its description, genetic background, and diagnostic process for decades; however, no effective prevention or treatment has yet been established. PAM is classified as an ultrarare lung disease linked to mutations in the autosomal recessive sodium-phosphate co-transporter gene SLC34A2, which may serve as a potential target for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
